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Abstract
In recent years, interest has surfaced in the use of insulin-mimicking agents for diabetic
therapies. Zinc has been shown to have insulin-like effects in vivo and in vitro but has
never been studied for its ability to mimic insulin in the regulation of carbohydrate and
fatty acid metabolism. Therefore, we studied the effects of zinc on gIucose-6-phosphate
dehydrogenase (G6PDH), an enzyme stimulated by insulin that is imperative in both
carbohydrate and fatty acid metabolism. Because G6PDH is highly regulated in liver cells,
a stable rat liver cell line, Buffalo Rat Liver (BRL), was used. Endogenous G6PDH activity

and G6PDH promoter activity were both significantly stimulated at 1 uM [Zn2+|. Two
antioxidants, trolox C and catalase, eliminated the zinc-induced increase of endogenous
G6PDH activity and G6PDH promoter activity respectively. Further studies were
performed to investigate whether zinc effects are produced due to the generation of reactive
oxygen species. Upon addition of trolox C and zinc, BRL cell death was decreased
compared to the zinc alone treatment. A compound known to eliminate glutathione, BSO,
had no effect on BRL cell viability. These results infer that the mechanism of zinc action
does involve the generation of reactive oxygen species (ROS) but that zinc does not produce
ROS through the depletion of glutathione. Zinc has also been shown here to be toxic only
at very high concentrations, a phenomenon seen with vanadate and selenate, two wellstudied insulin mimetics. The results presented here demonstrate that zinc regulates
G6PDH similarly to insulin and generates enthusiasm for zinc as a possible insulin mimetic

Introduction
Glucose-6-phosphate dehydrogenase (G6PDH—EC 1.1.1.49) is the rate-limiting enzyme in the

pentose phosphate pathway and a key contributor to carbohydrate and fatty acid metabolism. In
the fed state, as much as 60% of the glucose present is directed through the pentose phosphate
pathway. This pathway, which is regulated at the G6PDH reaction, supplies the body with both
NADPH, the major reducing equivalent and an essential participant in lipogenesis, and ribose-5-

phosphate, the sugar necessary for nucleic acid synthesis. Although G6PDH is considered a
'^housekeeping" enzyme, it is highly regulated in liver cells. Insulin, vanadate and selenate (insulin
mimetics), and reactive oxygen species (ROS) have all been shown to regulate G6PDH. In the

presence of insulin, liver G6PDH expression is increased through a cascade ofevents. This

cascade is initiated by insulin binding to the insulin receptor and mediated by tyrosyl

phosphorylation of signal proteins inthe phosphatidylinositol-3 (PI-3) kinase pathway {Journal of
Biological Chemistry in press). Vanadate and selenate, two postulated insulin mimetics, have

also been shownto induce the expression ofG6PDH in rat hepatocytes (Stapleton et al., 1995).

Furthermore, our lab and others have shown thatthe insulin receptor and some signal proteins in
the insulin pathway(insulin receptor substrate-1 (IRS-1), phosphatidylinositol-3 (PI-3) kinase,
and mitogen activated protein kinase (MAPK)) are activated by the presence ofvanadate and/or

selenate (Stapleton et al., 1996; Heffetz & Zick, 1989; Heffetz et al., 1990; unpublished results).
Recently, data showing that G6PDH expression may also be regulatedby the oxidative state of

the cell has been published. Diquat and ethanol, two compounds known to enhance oxidative
stress, have been shown to increase G6PDH activity at the transcriptional level (Cramer et al.,

1995; Kleitzen et al., 1994). BecauseG6PDH is the primary source ofNADPH, the major
reducmg equivalent responsible for rnaintaining the oxidative state of cells, it is not surprising that

G6PDH levelshave been shown to increase due to the presence of oxidative stressors. Figure 1

showsthe rolethat NADPH produced from G6PDH plays in reducing reactive oxygen species.
Understanding the regulation ofG6PDH by insulincomparedto insulinmimetics and ROS is
important for possible diabetic therapiesinvolving insulinmimetics.

Zinc, a postulated insulin mimetic, is an essential trace element (like selenium) that enters the cells

through a high affinity, saturable pathway (Taylor & Simmons, 1994). It is a cofactor for over
200 enzymes, some ofwhich play a role in maintenance ofcell functions including transport
processes and subcellular organelle integrity (Vallee & Auld, 1990). The concentration of zinc in
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the blood is approximately 15 uM, however, onlyabout 0.2 nM ofthat is not bound to albumin
(Taylor & Simmons, 1994).

Zinc has beenshown to have insulin-like affects at boththe organismal and cellular level. At the

organismal level, ZnCl2 administered orally to diabetic rats reduced blood glucose levels as much
as 50% after 2 hours oftreatment (Shisheva et al., 1992). At the cellular level, several studies

have shown thatthe presence ofzinc stimulates glucose transport and ifthfcks- Hpofysie inrat
adipocytes (Ezaki, 1989; May and Contoreggi, 1982). Zincaddition to adipocytes also increased

glucose oxidation by glycolysis and the pentose phosphate pathway (May & Contoreggi, 1982;
Shisheva et al., 1992) and stimulated lipogenesis (Coulston & Dandona, 1980). Like insulin, zinc

has been shown to bean antagonist of glucagon (cAMP) with regards to glycolysis regulation
(Brand & Kleineke, 1996).

Zinc has also been shown to increase oxidative stress inthe cell. Deibel et al. postulated that zinc
plays anoxidative stressor role inthe neurodegeneration hypothesis for Alzheimer's disease

(Deibel et al., 1996). Furthermore, metallothionein (MT), a known scavenger of free radicals, has

also been shown to protect mice against zinc toxicity invivo (Kelly et al., 1996). May and
Contoreggi postulate that zinc mimics insulin, in part, through the generation ofH2O2, a reactive

oxygen species, because insulin-like effects of zinc were inhibited upon catalase addition (May
and Contoreggi, 1982). However, the action of zinc due to the production ofH2O2 was not
confirmed in a later study (Ezaki, 1989).
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Oxidative stress on the cell is produced through the generation of free radicals and other reactive

oxygen species. A free radical is defined as any species that hasone or more unpaired electrons

(HaUiwell & Gutteridge, 1984). Oxygen free radicals include hydroxyl radical (OH*), superoxide

(02), alkoxyl (RO*), and peroxyl (ROO*) radicals (Pietrangelo, 1996). Although H202 does not
have one or more unpaired electrons, it causes similar effects as the oxygen free radicals and is

easily converted to the very toxic OH* radical as shown in Equation 1. Collectively, oxygen free
radicals andhydrogenperoxide are referred to as reactive oxygen species (ROS). The oxidation

ofbiological molecules, membranes, and tissue by ROS is associated with such pathological
events as cancer, aging, and diabetes mellitus (Paolisso & Giugliano, 1996). Furthermore, ROS

can cause DNA damage, activate procarcinogens, damage proteins, cause lipid oxidation, and

alter the cellular antioxidant system(Bagchi et al., 1997; Paolisso & Giugliano, 1996).

It is not surprising that zinc has been shown to generate oxidative stress because transition metals,

which frequently haveunpaired electrons, are excellent catalysts for the generation ofoxidative

stress. Two primary mechanisms through which metals induce oxidative stress are 1) single e*
withdrawal and 2) depletion of glutathione. Throughthe transfer of single electrons, metals can
cause the formation ofROS by catalyzing the reactions shown in Equation 1.

Equation 1: 02 —^-» 02" ^i£» H202 -2^£» OH*
Iron and copper haveextensively been studied and shownto produce highly reactive hydroxyl
radicals by the mechanism outlined in Equation 2 (Deibel et al., 1996; Freeman & Crapo, 1982).

Equation 2: M^ + H^

> M(n+1)f + OH* + OH"

Co +and V +are also capable of oxidizing various compounds by single-electron withdrawal.
However, othermetals cancreate oxidative stress through depleting glutathione. Glutathione has

a high affinity for metals and is a substrate in the reduction ofH2O2 by GSH peroxidase as shown
in Figure 1. Reduced levels of glutathione increase the susceptibility of cells to damage by H202

because the natural defense mechanism against ROS (Figure 1) is compromised (Paolisso &

Giugliano, 1996). Cd2+, Hg2+, Ni2+, and Pb2+ increase oxidative stress through the depletion of
glutathione (GSH) (Stohs & Bagchi, 1995).
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Figure 1
Role ofG6PDH in the natural defense mechanism against reactive

oxygen species

Zinc, because it exists solely in the divalent state, is unlikely to participate in Equation 1 to
produce ROS (May and Contoreggi, 1982). However, zinc has been shown to be a potent
inhibitor of glutathione reductase (GSSG reductase) in Uver homogenates (Mize et al., 1962) and
may generate oxidative stress by inhibiting the reduction of GSSG to GSH, thereby depleting
glutathione levels. However, the mechanism by which zinc causes oxidative stress is still unclear.

In recent years, interest has surfaced in the use of insulin-mimicking agents for diabetic therapies.
It is, therefore, important to assess if postulated insulin mimetic agents control carbohydrate and
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fatty acid metabolism similarly to insulin. One way to do this is to observethe effect insulin-

mimetics have on G6PDH activity. Zinc, anagent thathas been shown to have many insuhn-like
effects, hasnever beenstudied for its ability to stimulate the expression of G6PDH or anyother
enzymes in fatty acid or carbohydrate metabolism, Thus* it was my goalto study the effect of
zinc on G6PDH activity in Buffalo Rat Liver (BRL) cells. Furthermore, since G6PDH is

regulated by ROS, it is important to assess if zinc effects on G6PDH are caused by the generation
ofROS. In order to do this, 1) the effects on endogenous G6PDH activity were tested with
treatments of zinc and an agent that affects ROS production, 2) the effects on the expressionof

the G6PDH promoter were tested with treatments ofzinc and an agent that affectsROS, and3)
the effects on cell viability were examinedwith treatments of zinc and agentsthat affect ROS
production.

Experimental Procedures
Materials

ZnCl2 was used as a source of [Zn2+]. Buthionine sulfoximine (BSO) and trolox C were
purchased from Aldrich Chemical Company, Milwaukee, WI. DMEM-F12 media was obtained

from Life Technologies. The luciferase assaykit was obtained fromthe Promega Corporation.

Cell Culture

Buffalo Rat Liver (BRL) cells, a stablerat hver cell line, were used to study theefieets of zme on
ghieose-6-phosphate dehydrogenase (G6PDH>. TheBRL cells were growrhmDMEM-F12 media
with 5% serum at 37°C under a 5% C02 atmosphere. When the cell culture flasks or dishes were

75-85% confluent, the media was replaced with serum-free DMEM meora for 241x>urs. Various

treatments were then added according to each study. In the gene expression study, BRL cells

transfected with the lueiferase reporter gene driven by the935 bp promoter region ofG6PDH
were used to investigate the effectof zinc on the transcriptional activity ofG6PDH. Figure 2
displays the plasmid used to create the stably-transfected cells and Figure 3 shows the G6PPH
promoterregion with various regulatory elements. The exogenous DNA in the host cell was

ensured by selective pressure using a co-transfected plasmid which coded for a

phosphotransferase capable ofenzymatically deactivating G418, a neomycin analog, the stabrytransfected BRL cells were created by Mr. Jason Leduc.
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Figure 2

pGL2—Basic Vector with G6PDH promoter insert. Plasmid
construct containing the 935 bp promoter region ofG6PDH linked
to the lueiferase reporter gene. Basaltranscription ofthe
downstreamlueiferase reporter gene is driven by the G6PDH
promoter.
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ccagaagtga agagggcagg ageageggea gaateggage tcctaggaaa tcctagtcag

61

gcggtcaccc ttcccttctc agcagtggaa aaccccactt cggcttccgg tgtcgtaagt

121

gtgggatccg gaagtaaaac acagactcaa aggcattaat actagagagt taaaactccg

181

aagtgccaca ctctgctcca aagtcttaga ccgccagcct gcgttggcca geggaacage

241

agaatgctcc ttactgataa acatcacaac tcttatacac acaatttttt ttttggacag

301

ggteetaegt agaeeagaet ageeteggae teagagatee aeetgeettt ttteegteta

361

ctgggattaa agcagtgagt caccatgtcc acactcgctc tcaccccatt ttcaaggcat

421

cgcatcctca

481

tagaggaagc tgcgaaactt gggccccaga agecaaacta gectcaggaa ggcgtggcta

541
601

egtgetaaeg gaagtggggt catcegggaa ggtgeaggge ettgggggea geggaaaget
CREB:tgacgt ca
agaccataca ttatggctgg ggagactaag ggaatacagg agaactgagt ggagctgeae

661

caatgcaagc aagacatcgc gatcgeggea ggggcatcag ggacggccaa aggeggagtt

721

cgcgggattg cgcgcgcatt tatctctact cttctccccc ccctcctccc ccgcactgat
MRErtg cgccc
agagtageee gaagcteete eeegetgeet eteetgageg gggteagete agtcaaagca

C/EBP:tgtggaa

ag

AP-l:gactcga

AP-l:gac

ctaaaacacc

tGga

XRE: eaegena
cctggctctc tgetgecagg cccctactaa gttaaaagtc

AP»2:cc ccaggc

•

glucrgacggc

781

AP-i:g actcga
cacgccctct tgcgttaaat gggecaaega agcttagccc ccggaaacgc tgtgcactac
XRE :eaegeh
*TATA box"
901 agatctgtga acgtgtttgg cagcggcaac taaat
841

Fieure3

Sequence ofthe 935 bp ofrat G6PDH DNA that contains the promoter region. This
promoter region is 1the G6PDH sequence that drives lueiferase transcriptiorlin the plasmid
construct shown in Fig. 3. A metal response element (MRE) is postulated to occur at

729 to 735 bp. Other regulatory elements are also noted.

G6PDH Assay

The G6PDH activityassay was performed according to Glaser & Brown, 1955. After 48 hours of
zinc treatment, the mediawas aspirated and 1 mL of0.1 M potassium phosphate buffer was
addedto each flask. The cells were then scraped offthe flask, homogenized, and ccntrifuged to
remove the membranes. The G6PDH activity ofthe rysates (supernateht) was measured
spectrophotometricallyat 340 nm by following the reduction ofNADP to NADPH in the
presence of glucose-6-phosphate (G6P). In a one mL assay, the final concentrations ofreactants

were 86.3 mM triethanolamine buffer(pH 7.5), 5 mM MgCl2,1.2 mM G6P, and0.37 mM

NADP. A lOOuL aliquot ofcytoplasmic sample was added to the solution ofbuffer, MgCfc, and
NADP in a cuvette. The reaction was started with the addition of G6P and is linear for

approximately 5 minutes. Because the activity ofthe enzyme is measured asthe slope ofthe

linear line associated withthe formation ofNADPH, it is important that the samples are assayed
shortly after G6P is added. A 200uL aliquot wasalso assayed and should produce a rate double
that ofthe lOOuL sample because the rate is proportional to the amount of enzyme added.

LDH Assay

The lactate dehydrogenase (LDH) assay was performed according to Wrbblewski & LaDue,
1955. The assay for LDH, an intracellular enzyme released into the extracellular media when cell

membranes are compromised, was used as a measure ofthe point at which zinc began to
compromise the cellmembranes. LDH catalyzes the reduction of pyruvate to lactate with the

subsequent oxidation of NADH to NAD+. After 48 hours of zinc treatment, a sample of media
wasobtained in order to measure the amount of LDHreleased by the cells. The assay measures

the linear, LbKkcataiyzed oxidation ofNADH in the presence of pyruvate spectrophotornetrically
at 340 nm. The final concentrations ofreagents ina onemL assay were 83 mM potassium
phosphate buffer, 0.67 mM pyruvate, and 0.23 mM NADH. A media sample was added to the
buffer and pyruvate in a euvette^ followed by the addition ofNADH which initiates the reaction
Media samples of lOOuL and 200uL were assayed.
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Lowry method for protein determination

The samples were assayed for protein_concentration using the Lowry method (Lowry et al.,
1951). The principle behind the Lowry method is a comparison between the amount of color

development from known pure proteins and that ofexperimental samples. Color develops due to

the formation ofa purple protein-copper complex when the peptide nitrogen atoms combine with

Cu2+. Color also appears due to the reduction of the phosphomolybdate-phosphotungstate
reagent (Folin-Ciocaltenreagent) with tyrosine and tryptophan residues. In this procedure, 50
mL of 2% Na2C03 in 0.1 N NaOH, 0.5 mL of 2% sodium potassium tartrate, and 0.5 mL of 1%

Q1SO4 were mixed together. Two mL ofthis solution was added to an appropriate amount of
sample in a test tube. The amount of sample varies because the concentration range ofthe assay

is 5-100 ug of protein. This mixture of solution and sample was mixed well and allowed to stand
at room temperature for ten minutes. After which, 0.2 mL of IN Folin-Ciocalten "phenol
reagent" was added to the test tube and color was allowed to develop for 30 minutes. Next, the
samples were placed in cuvettes^and the absorbance was read at 500 nm on the

spectrophotometer. Along with the experimental samples, a "standard protein" of known
concentration was assayed and used to construct a calibrationcurve using a best fit ofthe line
through the standard protein absorbance values. In this procedure, bovine serum albumin (BSA)

was used as the standard protein. The amount of protein in the experimental samples was
•

determined by comparing the absorbance ofthe experimental sample to the best line fit ofthe
BSA standard. The concentration ofthe protein in the sample is important to calculate the
specific activity (rate/concentration) ofthe enzyme. This specific activity can then be compared
to the specific activity ofother samples.
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Lueiferase Assay

The lueiferase assay is based on themeasurement oflight emitted from the oxidation ofluciferin

catalyzed by lueiferase. Promega's Lueiferase Assay system was used for this assay. The
lueiferase gene acts as areporter gene for the G6PDH promoter located upstream. After 6 hours
of zinc treatment on the stably-transfected cells, the media was aspirated and the cells washed
with phosphate-buffered saline (PBS). Next, IX lysis buffer from the assay kit was added to the

flask and the cells were scraped off the bottom. After 15 minutes ofallowing the cell material to

lyse, the solution was placed inan eppendorftube and the debris was collected bycentrifugation
at 14,000 rpm. The lysate (supernatent) was then assayed for lueiferase activity quantified by a

scintillation counter. Experimental samples were added to lOOuL ofluciferin (substrate) to
commence thereaction. Due to the speed ofthereaction, it was important that the samples and
luciferin were in solution together for less than oneminute before quantifying.

Fluorescence Viability Assay

The fluorescence viability assay was performed according to Yazdanbakhsh et al., 1987 with

some modifications. Aftertreatments, the media was aspirated and washed withphosphatebuffered saline (PBS). Ethidium bromide (lOug/mL) was added to celldishes andthe number of
dead cells were scored using fluorescence microscopy. Fluorescein diacetate was not usedto

stain the living cells dueto problems ofdiffraction associated with the plastic culture dishes.
Trolox C (6-hydro-2,5,7,8-tetramethylchromane-2-carbonic acid) (Strubelt et al., 1996) and
buthionine sulfoximine (BSO) were agents used to alter the oxidative state ofthe cell. Trolox C

wasdissolved in distilled water by first adjusting the pHto 12and thenreadjusting the pHto 7.4
(Wuetal., 1996).
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Statistical Analysis

The lueiferase, LDH, and G6PDHactivities are presentedas fold increases from the no addition

control. Activity perunit of protein was used as the specific activity ofeach sample. Fluorescent
viability study results are shownas percentage ofviable cells per flask. Results are reported as
means +/- SEM. A one-tailed students t-test was used to indicate significance (p<0.05).

Results
Effects of zinc on endogenous G6PDH activity. BRL cellswere treatedwith varying
concentrations of zinc for 48 hours and assayed for endogenous G6PDH activity. Protein
concentrations were measured to determine the specific activity ofG6PDH. A concentration-

dependent effect of zinc on G6PDH activity is shown in Figure 4. Maximal zinc stimulation of
G6PDH occurred at 1 uM. The fold increase in G6PDH activity at this concentration matched

the fold increase in G6PDH activity from the insulin treatment. The increases in G6PDH activity

at 0.5,1,and 5 uM [2n2+] were sigriifieant compared to the noaddition control This finding is
animportant first step in investigating whether zinc stimulates carbohydrate and fatty acid
metabolism similarly to insulin.

ttr

Ctect oi 7n nn nnitoganous G6P0H activity- in Buffalo Rat Liver ceils
3.5

3

2.5

5

1.5

0.5

0

o

Treatments

Figure 4
Effect of zinc on endogenous G6PDH activity in Buffalo Rat Liver cells, ZnCfc was used as

the source of [Zn2+], Ins=insulin treatment (300ng/ml). The cells were treated with zinc
concentrations for 48 hours and incubated in DMEM media. An insulin treatment was used

to compare the effects of zinc to insulin, [Zn2+] significantly increased, equivalent to insulin,
the endogenous G6PDH activity. Maximal stimulation occurred at 1 uM [Zn2+]. The results
are displayed as fold increase from the no additioncontrol (NA).
* Indicates significance (p<0.05); n=5

Effect and mechanism of zinc on G6PDH expression using a reporter construct. Cells

stably-transfected with a plasmid (Figure 2) containing 935 bp ofthe G6PDH promoter region
driving the lueiferase reporter gene were used to investigate the effect of zinc on the recently
isolated G6PDH promoter region (Figure 3) (Rank et al., 1994). Because lueiferase is not found

in mammals, any lueiferase activitymust be from the induction ofthe gene located on the plasmid.
If zinc stimulates the expression ofG6PDH transcriptionally by acting on the G6PDH promoter,
then lueiferase activity will be present. The stably-transfected BRL cells were treated with 1 uM
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[Zn2+] for 6 hours. Figure 5 shows that 1 uM [Zn2+] treatment resulted in more than atwo-fold
increase in lueiferase activity which matches the increase in endogenous G6PDH activity
associatedwith this treatment. In order to determine whether the induction ofG6PDH by zinc
could be due to the generation of reactive oxygen species, cells were treated with a catalase + zinc

treatment. Catalase does not enter the cells but eliminates extracellular H2O2 by catalyzing
Equation 3.
Equation 3: 2H202

> 2H20 + 02

Because intracellular and extracellular H202 concentrations are at equilibrium, it is assumed that

catalase decreases to concentration of H202 inside the cell by causing H202 efflux. The zinc +
catalase treatment returned the lueiferase activity to the no addition control value. This suggests

that H2O2 is important in the zinc-induced increase in G6PDH promoter activity.
mm^li*imi*tm*m***n**mmmmmBmmntmmrTt*seitrxr*TT*rz ',La,.iuv.j.M,i:ta,;a^ujij'^^viMiaj,[«i;i^^^^

Effect of Zn en Lueiferase Activity after 6h Treatment

I 2.5

I
! 2

I 0.3

1pM Zn + Cat

Figure 5

Effect ofzinc on lueiferase activity after 6 hours. ZnCl2 was used as the source of [Zn2+].
Lueiferase transcription was driven by the G6PDH promoter region in the plasmid construct. 1

uM [Zn2+] treatment resulted ina2.0-fold increase inlueiferase activity. This suggest that zinc
acts transcriptionally to promote an increase in G6PDH activity. Catalase (130 U/ml), an
antioxidant, restored the lueiferase activity to the no additionvalue suggestingthat the
mechanism of zinc actionmay be due to the generation ofROS. The results are displayed as
fold increase from the no addition control (NA).

* Indicates significance (p<0.05), n=4
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Mechanism of zinc action on endogenous G6PDH expression. In order to further assess the
possible mechanism of zinc action at the concentration that induced maximal G6PDH activity,

endogenous G6PDH activity was measured with a treatment of 1 uM [Zn2+] and trolox C. Cells
were treated with zinc and/or trolox C for 48 hours. Figure 6 shows that trolox C effectively

eliminated the increase inG6PDH activity seen with 1 uM [Zn2+], Trolox C alone created a slight
significant increase in G6PDH which is unexplained. Reactive oxygen species appear to play a
role in the zinc-induced increase in endogenous G6PDH activity and G6PDH promoter activity.

Effect of Zn and trolox C on endogenous G6PDH activity

1 pMZh

TrdOKC

1 \jM Zn + trdox C

Treatments

Figure 6
Effect ofzinc and trolox C on endogenous G6PDH activity. ZnCk was used as the source of

[Zn2+]. Cells were treated for 48 hours and then assayed for G6PDH activity. Trolox C
effectively reduced the zinc-induced increase in G6PDH activity. Therefore, it is evident that
ROS play a role in the inductionof G6PDH activityby zinc.
* indicates significance (p< 0,05) compared to the no addition control (NA). ** indicates

significance compared tothe 1 uM [Zn2+] treatment; n=3
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Assessment of zinc toxicity. The decrease in endogenous G6PDH activity (Figure 4) at zinc

concentrations of 5 uM and 10 uM occurred because the cells werecompronaised as zinc began
to exert toxic effects. To assess toxic zinc effects, the media of the cells treated with zinc was

measured for LDH activity, a compound that is released by alive cells into the media due to
compromised membranes. Figure 7 shows the LDH activity at appropriate zinc concentrations.

At 5 uM zinc, the LDH activityincreased significantly suggestingthat zinc beginsto cause cell
membranes to be compromised at this concentratioa The decrease in LDH activity at 10 uM is

indicative of cell death. A lack of increased LDH activity at 1 uM [Zn2+], theconcentration that
induced maximal G6PDH activity, suggests that this concentration does not significantly
compromise the cell membranes.
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Effect of Zn on LDH activity in Buffalo Rat Uver cells
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Figure 7
Effect of zinc on LDH activity in Buffalo Rat Liver cells. ZnCl2 was used as the source of

[Zn2+]. Ins=insulin treatment (300 ng/ml). LDH, an enzyme released by compromised
membranes, is a common indicator oftoxicity. BRL cells were treated for 48 hours with

varying concentrations of zinc or insulin and the media was assayed for LDHactivity. Cells

were significantly compromised at 5 uM [Zn2+]. At 10 uM [Zn2+], cell death was indicated.
Neither insulin nor the optimal concentration of zinc for maximal G6PDH activity showed a
significant increase in LDH activity compared to the no addition control. The results are

displayed as fold increase from the no addition control(NA). * Indicates significance
(p<0.05); n=3 for 0.5, 5,10 uM [Zn2+], n=4 for all other treatments

Mechanism of zinc action. In order to further investigate the potential role ofROS in the
mechanism ofzinc action, flasks were treated with zinc and agents that alter the oxidative state of

the cell. Cellviability was then quantified. The results using trolox C are shown in Figure 8 and

the results using BSO are shown in Figure 9. TroloxC is a water-soluble analog of Vitamin E
and a known antioxidant that protects against lipid peroxidation (Chen& Tappel, 1996) and ROS
in rat hepatocytes (Wu et al., 1991). It enters the cell and thus can sequester intracellular oxygen
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radicals. Cells were treated with zinc and 2mM trolox C. After 24 hours of treatment, the media

was aspirated and percent viability scored. The percent of dead cells was quantified using

fluorescence microscopy to visualize ethidium bromide chelated to the DNA of the dead cells.
Trolox C had a slight but significant protective effect on the cell viabilityof BRL cells treated

with zinc at and below 90 uM. At very high zinc concentrations, trolox C had no effect possibly
due to an overabundance of ROS. This data suggest that zinc, in part, could produce toxic effects
due to the generation of free radicals (ROS). Although trolox C did not have a significant effect

on cell viability at 1 uM [Zn2+], very little cell death at this concentration made it difficult to
assess the effect of trolox C on cell viability at this concentratioa However, the effects caused by
zinc at higher concentrations appear to involve the generation of ROS and, therefore, ROS must
also be formed at lower zinc concentrations but may not induce cell death.
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Figure 8

Effect of zinc and trolox C on Buffalo Rat Liver cell viability. ZnCl2 was used as the source of

[Zn +]. BRL cell viability was measured using fluorescence microscopy after treatments of zinc
and trolox C (2mM) for 24 h. Ethidium bromide was used to stain the DNA ofthe dead cells.

The significant, slightly protective effect oftrolox C suggest that the mechanismof zinc action in
part involves the generation of ROS. However, at high concentrations of zinc, no effect oftrolox

C could be seen. Results are shown as percent viable cells. * indicates significance (p< 0.05)
compared to the same [Zn2+] treatment without trolox C, n=4
Zinc and BSO were added to BRL cells to investigate ifthe mechanism of zinc action involves the

generation ofROS by depletion of glutathione. BSO is a synthetic amino acid that depletes
glutathione by irreversibly inhibiting gamma-glutamylcysteine synthetase. Inhibition ofthis
enzyme eliminates a critical step in glutathione biosynthesis (Keogh et al., 1994;Bironaite &

Ollinger, 1997) and thus inhibits the body's natural defense mechanism against ROS (Figure 1).
The BRL cells were pre-treated with BSO for 24 h and then treated with zinc. After

approximately 24 h ofzinc treatment, the cells were scored for percent viability. Figure 9 shows
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that zinc's toxic effects werenot significantly altered dueto4he elimination ofGSHbyJBSO,
BSO alone at higher concentrations did show a decreased cellviability in a concentration
NA
dependent
manner. A slight, nonsignificant decrease incell viability canbe seen with treatment

BSO(2mM)

of both zinc and BSO.
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Figure 9

Effect of zinc and BSO on BRL cell viability. ZnCl2 was used as the source of [Zn2+]. BRL cell
viability was measured using fluorescence microscopy after treatmentsofzinc and BSO (2mM
unless otherwise noted) for 24 h. Ethidium bromide was used to stain the DNA ofthe dead cells.

Results are shown as percent viable cells. * indicates significance (p< 0.05) compared to the same

[Zn2+] treatment without BSO, n=4
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Discussion
It is important to assess whether possible insulin mimetics regulate carbohydrate and fatty acid
metabolism as insulin does. One wayto do this is to studyG6PDH, the rate-limiting enzyme in
the pentose phosphate pathway which is important in both carbohydrate and fatty acid
metabolism. Insulin increases G6PDH activity through a phosphorylation cascade of events that

includes the insulin receptor, IRS-1, PI-3 kinase, and S6K (JBC in press). Vanadate and selenate,

two transition metals and postulated insulin mimetics, have also beenshown recently to stimulate
G6PDH activity (Stapleton, et al. 1995). Zinc, also a transition metal, has been shown in several

studies to have insulin-like effects in vivo and in vitro (Shisheva et al., 1992; Ezaki, 1989; May &
Contoreggi, 1982; Coulston & Dandona, 1980) but its effects on G6PDH activity haveneverbeen

studied until now. The results inthis studydemonstrate that zinc does mimic insulin by increasing
G6PDH activity. This is a key step into investigating the insulin-like effects of zinc on

carbohydrate and fatty acidmetabolism. The mechanismby which zinc exerts this effect is still
unclear, but the generation ofROS is suggested.

Figure 4 shows that zinc effectively stimulates G6PDH activityto the same extent that insulin
does. Furthermore, it is suggested that this stimulation is due to a zinc effect on the G6PDH

promoter as demonstrated by the results shown in Figure 5. The finding that zinc increases

G6PDH activity demonstrates that zinc does regulate one aspect of carbohydrate and fatty acid
metabolism like insulin and the insulin mimetics, vanadate and selenate. However, the mechanism

through which zinc exerts its action needs to be further investigated.
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One possible explanation for the zinc-induced increase in G6PDH activity is that zinc increases

oxidative stress onthe cell. Several studies have shown that increased G6PDH activity is seen
whencells are treated withcompounds known to produce ROS (Cramer et al., 1995; Kleitzen et
al., 1994) probably because a major product ofthe reaction catalyzed by G6PDH is NADPH, the
major reducing compound in the body. Moreover, several studies have shown ROS to bcinsulin-

mimetics similar to vanadate and selenate. For example, H2O2, a common ROS, increases glucose
oxidation to C02, glucose uptake, lipogenesis, and glyeogenesis (Czech et al., 1.974; Lawrence &

Larner, 1978; May & de Haen, 1979a) Furthermore, hydrogen peroxide hasbeen shownto

stimulate tyrosine phosphorylation oftheinsulin receptor, and several signal proteins important in
the insulin signal pathway including IRS-1 and PI3K(Heffetz & Zick, 1989; Heffetz et al., 1990;
May & de Haen, 1979a). In feet, several studies have suggestedthat H202 acts as a second

messenger for insulin because insulin caused an increase in intracellular H2O2 production (May &
deHaen, 1979a; May &de Haen, 1979b). A recent study-onthe insulin-like effeet of H202 on
enzymes in carbohydrate metabolism showed that H2Q2 acts as an insulin mimetic in the

regulation of phosphoenolpyruvate carboxykinase, an important carbohydrate metabolism enzyme
(Sutherland et al.,-1997). Therefore, zinc, and possibly vanadate and selenate, mayexert insulin
like effects mediated by H202 or another ROS. The data in Figure 5 that shows a decrease in
zinc-induced G6PDH promoter activitydue to catalase supports this notion. Also, zinc-induced
endogenousG6PDH activitywas eliminated upon additionofan antioxidant, trolox C, which

again suggests that zinc's insulin-like effectswith regards to G6PDH regulation were caused by
an increase in ROS.
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Our lab has recently demonstrated that cadmium, a nonessential and extremely toxic metal that is
in the same periodic family as zinc, increases the expression of G6PDH in a concentration-

dependent mannerin Buffalo Rat Liver (BRL) cells. Furthermore, we have shown that this
concentration-dependent increase in G6PDH activity is inhibited by addition ofcatalase, an

antioxidant that eliminates H2O2. These results suggest that cadmium causes an increase in

G6PDH activity through the generation of ROS which is consistent with the zinc data presented

here. Although zinc and cadmiumareboth IIB transition metals, they differ in biological
significance because zinc is essential while the body recognizes cadmium as a toxic substance.

The results ofthe LDH leakage study demonstrate the non-toxic effects of zinc (Figure 7).
Unlike cadmium, zinc did not show an increase in LDH leakage at the concentration that
produced maximal G6PDH activity. Furthermore, concentrationsten-fold larger than the
concentration that produced maximal G6PDH activity were needed to cause cell death with zinc.
This non-toxic effect of zinc is more similar to vanadate and selenate than cadmium; however, the

effect of zinc on G6PDH appears to be similar to cadmium.

If zinc is an insulin-mimetic in similar ways to vanadate and selenate or if insulin-like effects of

zinc are mediated by hydrogen peroxide, zinc should cause phosphorylation ofthe insulin receptor
and other insulin signal pathway proteins. Hydrogen peroxide, vanadate and selenate have all

been shown to increase phosphorylation ofthe insulinreceptor and insulin signal cascade proteins
(Stapleton et al., 1996; Heffetz & Ziek, 1989; Heffetz et al., 1990; unpublished results). A recent
study however found that zinc does not stimulate the autophosphorylation or kinase activity ofthe

insulin receptor in rat adipocytes (Ezaki, 1989). But, the phosphorylation ofthese proteins was

quantified after only forty minutes of metal treatment. In a more recent study using selenate, it

24

was found that increased phosphorylation of insulin signal proteins was not seen until at least one

hour and was not maximal until at least three hours in rat hepatocytes and adipocytes (Stapleton
et al., 1996). Also, the study done by Ezaki concluded that cadmiumdoes not stimulate

phosphorylation of proteins involved inthe insulin signal cascade (Ezaki, 1989); however, data

from our lab has shown that cadmium does in fact stimulate phosphorylation ofinsulin signal
cascade proteins. This stimulation of phosphorylation by cadmiumwas not seen with incubations

less than one hour and was maximal withincubations much longer than one hour (unpublished
results). Therefore, it is apparent that metals take longer than other activators to cause increased

phosphorylation of insulin pathway signal proteins possibly due to the time needed to create ROS

which act as second messengers. And so, the lack of autophosphorylation or kinase activity ofthe
insulin receptor with zinctreatments suggested by Ezakimaybe caused by an incubation time that
was too short as was the case with cadmium.

Studies on the mechanism of zinc action were further done using BSO andtrolox C to affectthe
production ofROS. An increase in cell viability with trolox C addition was not seen until 5 uM

[Zn +] and this was slight. Large effects of trolox Cwere not seen until very high concentrations
of zinc suggesting that zinc toxicity involves the formation of ROS, Vanadate and selenate have

also beenshown to become toxic onlyat very high concentrations possibly through the generation
of ROS (unpublished results). This is consistent with other sunilaritiesbetween zme and vanadate

and selenate. An incomplete restoration to cell viability levels by trolox C suggeststhat zinc

toxicitymay involve othermechanisms besides the generation of ROS. This is supported by a
study ofvarious metals that concluded that metals are nonspecific toxicants and are involved in a

number ofmechanisms that affect cellviability (Strubelt et al., 1996). Althoughtrolox C did not
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cause an increase in cell viability at 1 uM [Zn2+], it is probable that slight amounts of ROS are

created at 1 uM [Zn2+] but these ROS formed are not enough to kill the cells.

A study on cellviability with zinc and BSO treatments was also performed to investigate the
mechanism of zinc action. BSO, an inhibitor ofthe body's natural antioxidant defense mechanism

by depleting glutathione (GSH), did not have an effect on zinctoxicity. Mize and Langdon found
that zinc inhibits hepatic glutathione reductase whichwould deplete GSH (Mize & Langdon,
1962) and leave the cell more susceptible to oxidative stress. Treatment of BSO, which

eliminates GSH, should have a potentiating effect when combined with zinc if zinc causes

oxidative stressthroughthe depletion ofGSH. However, the results displayed in Figure 9 do not
show a potentiating effect ofGSH on zinc toxicity. BSO also did not affect the toxicity of

cadmium in intestinal epithelial cells (Keogh et al., 1994). Keogh et al. suggested that cadmium
toxicity may involve the binding to specific high-affinity thiol groups and not glutathione (Keogh

et al., 1994). The zinc data presented here also suggests that zinc toxicity is not mediated through
binding ofGSH although more specific studies on GSH content with zinc treatments shouldbe
done to confirm or dispute this.

It is importantto note that the fluorescence cell viability assay distinguishes between cell death
and cell survival and therefore it is difficult to assess the effects oftrolox C and BSO at non-toxic

zinc treatments. However, zinc has been shown to cause cell death due, in partto ROS and so
zinc would also cause ROS at lower concentrations. The feet that these lower concentrations of

zinc are non-toxic yet still increase G6PDH activity suggest that G6PDH may act as a sensorto

even small amounts of ROS. The increase in G6PDH activity can eliminate the ROS by using
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NADPH to reduce these compounds. This appears to be the case with vanadate and selenate

(Berg et al., 1995) and, based on the results shownhere, zinc also appears to elicit such a
response. The non-toxic effect of zinc at 1 uM is confirmed by the LDH activity. Based on the

LDH study, cell death did not begin to occur until 10 uM [Zn2+] but membranes began to become

compromised at 5 uM [Zn2+]. Although the cell viability studies did not begin to show significant
cell death until 30 uM [Zn2+] while the LDH graph suggested cell death at 10 uM [Zn2+], it is
important to notethat cells were treated for 48 hours inthe LDH study and only 24 hours inthe

cell viability study. This time difference can be used to explain the difference intoxicity levels of
zinc between the LDH and cell viability studies.

These results generate enthusiasm for zinc asa possible insulin-mimetic and suggest a role ofROS
in the action of zinc. It also appearsthat G6PDH acts as a sensor ofnon-toxic ROS.

Furthermore, zinc has, for the first time, been shown to increase activity of animportant enzyme if
carbohydrate and fatty acid metabolism similarly to insulin. Further studies need to be done to

confirm the that zinc acts at the transcriptional leveland to investigate where on the G6PDH
promoterthe zinc action could be mediated. Also, further investigation into the mechanism of
zinc action is needed.
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